首页> 美国卫生研究院文献>Oxidative Medicine and Cellular Longevity >Ethanolic Extract of Senna velutina Roots: Chemical Composition In Vitro and In Vivo Antitumor Effects and B16F10-Nex2 Melanoma Cell Death Mechanisms
【2h】

Ethanolic Extract of Senna velutina Roots: Chemical Composition In Vitro and In Vivo Antitumor Effects and B16F10-Nex2 Melanoma Cell Death Mechanisms

机译:番泻叶番木瓜根的乙醇提取物:化学成分体内和体外抗肿瘤作用以及B16F10-Nex2黑色素瘤细胞死亡机制

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Cutaneous melanoma is among the most aggressive types of cancer, and its rate of occurrence increases every year. Current pharmacological treatments for melanoma are not completely effective, requiring the identification of new drugs. As an alternative, plant-derived natural compounds are described as promising sources of new anticancer drugs. In this context, the objectives of this study were to identify the chemical composition of the ethanolic extract of Senna velutina roots (ESVR), to assess its in vitro and in vivo antitumor effects on melanoma cells, and to characterize its mechanisms of action. For these purposes, the chemical constituents were identified by liquid chromatography coupled to high-resolution mass spectrometry. The in vitro activity of the extract was assessed in the B16F10-Nex2 melanoma cell line using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay and based on the apoptotic cell count; DNA fragmentation; necrostatin-1 inhibition; intracellular calcium, pan-caspase, and caspase-3 activation; reactive oxygen species (ROS) levels; and cell cycle arrest. The in vivo activity of the extract was assessed in models of tumor volume progression and pulmonary nodule formation in C57Bl/6 mice. The chemical composition results showed that ESVR contains flavonoid derivatives of the catechin, anthraquinone, and piceatannol groups. The extract reduced B16F10-Nex2 cell viability and promoted apoptotic cell death as well as caspase-3 activation, with increased intracellular calcium and ROS levels as well as cell cycle arrest at the sub-G0/G1 phase. In vivo, the tumor volume progression and pulmonary metastasis of ESVR-treated mice decreased over 50%. Combined, these results show that ESVR had in vitro and in vivo antitumor effects, predominantly by apoptosis, thus demonstrating its potential as a therapeutic agent in the treatment of melanoma and other types of cancer.
机译:皮肤黑素瘤是最具有侵略性的癌症之一,其发病率逐年增加。当前用于黑色素瘤的药物治疗尚不完全有效,需要鉴定新药。作为替代,植物来源的天然化合物被描述为新的抗癌药物的有希望的来源。在这种情况下,这项研究的目的是确定番泻叶乙醇提取物(ESVR)的化学成分,评估其对黑素瘤细胞的体外和体内抗肿瘤作用,并表征其作用机理。为了这些目的,通过液相色谱与高分辨率质谱联用来鉴定化学成分。在B16F10-Nex2黑色素瘤细胞系中,使用3-(4,5-二甲基噻唑-2-基)-2,5-二苯基四唑溴化物(MTT)测定并根据凋亡细胞计数评估提取物的体外活性; DNA片段化;坏死抑制素1抑制;细胞内钙,泛半胱天冬酶和caspase-3激活;活性氧(ROS)水平;和细胞周期停滞。在C57Bl / 6小鼠的肿瘤体积进展和肺结节形成的模型中评估了提取物的体内活性。化学成分结果表明,ESVR含有儿茶素,蒽醌和piceatannol基团的类黄酮衍生物。提取物降低了B16F10-Nex2细胞的活力,并促进了凋亡细胞的死亡以及caspase-3的活化,并增加了细胞内钙和ROS的水平,以及亚G0 / G1期的细胞周期停滞。在体内,ESVR治疗的小鼠的肿瘤体积进展和肺转移减少了超过50%。结合起来,这些结果表明,ESVR主要通过细胞凋亡而具有体外和体内抗肿瘤作用,因此证明了其作为治疗黑素瘤和其他类型癌症的治疗剂的潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号